Response Prevention or Response Permission? A Randomized Controlled Trial of the “Judicious Use of Safety Behaviors” during Exposure Therapy by Blakey, Shannon M.
 
RESPONSE PREVENTION OR RESPONSE PERMISSION?  
A RANDOMIZED CONTROLLED TRIAL OF THE “JUDICIOUS USE OF SAFETY 
BEHAVIORS” DURING EXPOSURE THERAPY 
 
Shannon M. Blakey 
 
A dissertation submitted to the faculty at the University of North Carolina at Chapel Hill in 
partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Department 






Jonathan S. Abramowitz 
Donald H. Baucom 
Stacey B. Daughters 
Kristen A. Lindquist 


























Shannon M. Blakey 






Shannon M. Blakey: Response Prevention or Response Permission? A Randomized Controlled 
Trial of the “Judicious Use of Safety Behaviors” during Exposure Therapy 
(Under the direction of Jonathan S. Abramowitz) 
 
Safety behaviors (i.e., actions performed to prevent, escape, or minimize feared 
catastrophe and/or associated distress) are typically eliminated during exposure therapy for 
clinical anxiety (i.e., response prevention). Yet some experts have called for the strategic and 
“judicious use” of safety behaviors during exposure to improve treatment 
acceptability/tolerability without diminishing its efficacy. Empirical findings regarding this 
debate are mixed and existing work is subject to several methodological limitations. The current 
randomized controlled trial incorporated longitudinal design and multimethod assessment to 
compare the efficacy and acceptability of traditional exposure and response prevention (E/RP) 
and exposure with judiciously used safety behaviors (E/JU). Adults with DSM-5 spider phobia 
(N = 60) were randomized to four twice-weekly sessions of E/RP or E/JU. Self-report and 
behavioral measures were administered at pretreatment (PRE), posttreatment (POST), and 1-
month follow-up (F/U). Participants exhibited large effects on all measures from PRE to POST 
with no change from POST to F/U. There were no significant group differences on primary or 
secondary outcomes. Exploratory analyses suggest that safety behaviors promote swifter 
behavioral approach toward feared stimuli but interfere with facets of inhibitory learning. 
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RESPONSE PREVENTION OR RESPONSE PERMISSION?  
A RANDOMIZED CONTROLLED TRIAL OF THE “JUDICIOUS USE OF SAFETY 
BEHAVIORS” DURING EXPOSURE THERAPY 
 
 
Substantial research documents the efficacy and effectiveness of exposure-based 
cognitive-behavioral therapy (i.e., “exposure therapy”) in the treatment of anxiety-related 
conditions such as generalized anxiety disorder (GAD), illness anxiety disorder (i.e., 
hypochondriasis), obsessive-compulsive disorder (OCD), panic disorder, agoraphobia, 
posttraumatic stress disorder (PTSD), social anxiety disorder, and specific phobia (Olatunji, 
Cisler, & Deacon, 2010). The core feature of exposure therapy is the repeated and prolonged 
confrontation of anxious patients with feared situations/stimuli. Although exposure therapy is the 
first-line intervention for clinical anxiety (American Psychiatric Association [APA] 2013; 
National Institute for Health and Care Excellence, 2005a, 2005b, 2013), not everyone who 
receives it benefits from this approach. For example, 15% of individuals receiving exposure for 
specific phobia fail to improve (Wolitzky-Taylor, Horowitz, Powers, & Telch, 2008) and 
treatment dropout rates reach as high as 45% (Choy, Fyer, & Lipsitz, 2007). Furthermore, up to 
50% of patients (for OCD; Simpson, Franklin, Cheng, Foa, & Liebowitz, 2005) show at least 
partial relapse after a successful course of exposure therapy, highlighting the need for strategies 
to maximize long-term outcome. In sum, although exposure therapy is the most effective 
treatment for clinical anxiety, there is considerable room for improvement. 
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Explanatory Models of Exposure Therapy 
Despite empirical support for exposure’s effectiveness, its underlying mechanisms of 
change are not fully understood. One explanatory model of exposure therapy draws from 
experimental animal and human research on basic learning processes (Craske et al., 2008; 
Craske, Treanor, Conway, Zbozinek, & Vervliet, 2014; Laborda & Miller, 2012; Lang, Craske, 
& Bjork, 1999; Myers & Davis, 2007). This inhibitory learning framework posits that fear-based 
associations (e.g., spiders are aggressive) are not “unlearned” during exposure, but instead forced 
to compete with safety-based associations formed during treatment (e.g., spiders are not 
aggressive). Following repeated successful exposure trials, a phobic stimulus is associated with 
both its original excitatory (danger) meaning and its new inhibitory (safety) meaning. Thus, the 
aim of exposure therapy from this perspective is to help patients generate and strengthen 
inhibitory associations relative to older, fearful associations.  
Inhibitory learning theory emphasizes two important mechanisms: (a) expectancy 
violation and (b) decontextualization of inhibitory associations. Expectancy violation refers to 
the discrepancy between a patient’s anticipated exposure outcome (e.g., being bitten by a spider) 
and the actual consequence (e.g., not being bitten by a spider). This is based on research showing 
that inhibitory learning is achieved to the extent that individuals are “pleasantly surprised” by the 
incongruity of the predicted and observed events (Rescorla & Wagner, 1972). In clinical terms, 
this suggests that a patient is most likely to benefit from an exposure task that is designed in a 
way that maximizes the perceived probability of a feared outcome. For example, a therapist 
could help a patient test the prediction that sustaining an elevated heart rate for 15 minutes will 
lead to heart attack by having the patient induce elevated heart rate for at least 15 minutes (e.g., 
Deacon et al., 2013). 
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Importantly, excitatory learning is context-independent, meaning that learned fear of a 
particular stimulus in one context easily generalizes to other contexts. Inhibitory learning, in 
contrast, is context-dependent; learned safety does not generalize as easily because inhibitory 
associations are inferior in strength and accessibility to excitatory associations after a context 
shift (Bouton, 2002). Accordingly, inhibitory learning theory emphasizes the need to 
decontextualize (i.e., generalize) inhibitory associations by repeatedly violating expectancies in 
diverse contexts. Although the importance of conducting exposure in multiple contexts has long 
been understood, inhibitory learning theory advocates for using novel therapeutic strategies (e.g., 
introducing variability into exposure tasks; Craske et al., 2014; Jacoby & Abramowitz, 2016) to 
help patients generalize inhibitory associations outside the therapeutic context.  
Though not altogether incongruous with other explanatory models of exposure therapy 
(Clark, 1999; Foa, Huppert, & Cahill, 2006; Foa & Kozak, 1986; Foa & McNally, 1996; 
Salkovskis, Hackmann, Wells, Gelder, & Clark, 2006), inhibitory learning theory deviates from 
other frameworks in that it emphasizes the promotion of distress tolerance (i.e., developing a 
greater ability to withstand unpleasant psychological states) rather than distress reduction (i.e., 
striving to achieve a decline in fear/anxiety; see Craske et al., 2008, 2014). This is because 
patients can maximally violate their fear-based predictions for harm across multiple contexts to 
the degree that they are willing to experience psychological distress (Abramowitz & Arch, 2014; 
Blakey & Abramowitz, 2016). Therefore, patients receiving exposure from within an inhibitory 
learning framework are encouraged to focus on how well they are managing despite their distress 
instead of focusing on how elevated their distress is in the moment. 
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Safety Behaviors and Clinical Anxiety 
Safety behaviors are overt or covert actions performed to prevent, minimize, or escape a 
feared catastrophe and/or associated distress (e.g., Telch & Lancaster, 2012). To illustrate, a 
woman with a fear of enclosed spaces may avoid attending parties (i.e., prevent feeling trapped), 
repeatedly tell herself “relax” at parties (i.e., minimize her anxiety associated with being in an 
enclosed space), or leave a party after it becomes “too crowded” (i.e., escape the enclosed space 
and associated distress). Safety behaviors are functionally distinct from nonpathological safety 
maneuvers (e.g., adhering to an elevator’s passenger limit) or adaptive coping (e.g., telling 
oneself “it’s okay if I feel trapped;” Thwaites & Freeston, 2005). That is, whereas attempts to 
remain safe when faced with actual threat are adaptive, performing such behaviors in the absence 
of threat is unnecessary and may even exacerbate psychopathology (Helbig-Lang & Petermann, 
2010).  
It is understood that safety behaviors contribute to the development and maintenance of 
clinical anxiety (for a review, see Helbig-Lang & Petermann, 2010); accordingly, patients’ safety 
behaviors are traditionally eliminated as soon as possible during treatment (i.e., response 
prevention). This is because safety behaviors are thought to prevent the correction of mistaken 
threat-related beliefs by (a) absorbing finite attentional resources available to process and encode 
disconfirmatory information during exposure ( e.g., Sloan & Telch, 2002) and (b) causing 
anxious individuals to misattribute the non-occurrence of a feared catastrophe to the safety 
behavior (e.g., “If I hadn’t sat down when my heart started racing, I would have had a heart 
attack”; Salkovskis, 1991). More recently, others have argued that safety behaviors might 
interfere with the mechanisms believed to drive inhibitory learning (see Blakey & Abramowitz, 
2016). Specifically, safety behaviors are thought to prevent the (a) violation of negative 
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expectancies by attenuating the discrepancy between the predicted versus actual outcome when 
confronting a feared situation/stimulus, (b) generalization of safety-based associations by 
contextualizing inhibitory learning to specific contexts, and (c) development of distress tolerance 
by precluding patients from learning that they can persist despite their distress.  
Yet some have questioned the clinical convention of response prevention during exposure 
therapy. Specifically, Rachman, Radomsky, and Shafran (2008) proposed the judicious use of 
safety behaviors: the careful and strategic incorporation of safety behaviors during exposure, 
with an emphasis on the earlier or more challenging stages of treatment. Proponents of the 
judicious use of safety behaviors highlight their several possible advantages. For example, 
Rachman and colleagues (2008) argued that permitting safety behaviors during exposure might 
enhance treatment acceptability and tolerability without diminishing its efficacy. Others have 
suggested that safety behaviors facilitate exposure by (a) accelerating the rate at which patients 
approach exposure stimuli and/or (b) promoting closer approach to exposure stimuli (e.g., Hood, 
Antony, Koerner, & Monson, 2010). From the lens of inhibitory learning theory, it is also 
possible that safety behaviors maximize opportunities to violate negative expectancies by 
stimulating patients to conduct more (or more challenging) exposures than they would otherwise 
be willing to attempt. Furthermore, safety behaviors might help generalize inhibitory 
associations by making novel contexts less threatening (Rachman et al., 2008). The role of safety 
behaviors during exposure has garnered substantial research attention, yet study findings are 
mixed. Empirical findings related to the prevention versus permission of safety behaviors during 
exposure therapy are discussed next. 
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Safety Behaviors Interfere with Exposure Therapy 
Substantial research shows exposure with response prevention is associated with superior 
outcomes relative to exposure in which safety behaviors are permitted (Meulders, Van Daele, 
Volders, & Vlaeyen, 2016, for a review). Several theories have been offered to explain why 
safety behaviors reduce exposure’s effectiveness. Specifically, the use of safety behaviors during 
exposure is thought to (a) elicit misattributions of safety, (b) disrupt therapeutic information 
processing, and (c) interfere with inhibitory learning.  
Safety Behaviors Elicit Misattributions of Safety 
In his misattribution of safety hypothesis, Salkovskis (1991) posited that when anxious 
patients’ feared catastrophes do not occur in the context of safety behaviors, patients credit their 
safety behaviors for positive outcomes rather than modifying their threat-related beliefs. Despite 
being the most commonly cited explanation for why safety behaviors interfere with exposure, 
scant research has directly assessed safety attributions following exposure in relation to safety 
behavior use. Nevertheless, indirect evidence does support Salkovskis’s hypothesis.  
Risk of relapse is greater for patients who attribute improvement to external factors (i.e., 
medication) rather than to internal factors (i.e., their ability to manage physiological discomfort; 
Biondi & Picardi, 2003). To test this notion in an exposure context, Powers, Smits, Whitley, 
Bystritsky, and Telch (2008) examined the association between improvement attributions and 
return of fear following a 30-minute exposure for claustrophobia. Participants conducted 
exposure to a claustrophobia chamber after ingesting a pill described as either: a sedative that 
would make exposure easier, a stimulant that would make exposure more difficult, or a placebo 
that would not affect the exposure’s difficulty. Results showed that participants randomized to 
the “sedative pill” condition demonstrated greater return of fear (i.e., relapse) at 1-week follow-
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up. Findings suggest that attributing successful exposure outcomes to external rather than 
internal factors interferes with long-term fear extinction. However, this study was limited by its 
use of a nonclinical sample, short follow-up period, and lack of idiographic attribution data.  
Other researchers have invoked Salkovskis’s (1991) misattribution of safety hypothesis to 
explain greater reductions in catastrophic beliefs when safety behaviors were prevented, versus 
permitted (Kim, 2005; Salkovskis, Clark, Hackmann, Wells, & Gelder, 1999; Wells et al., 1995). 
Given these studies’ lack of ideographic attribution data, however, they only partially support the 
misattribution of safety hypothesis. That is, because these studies did not ask participants to 
report exposure outcome attributions (e.g., “the reason I didn’t shake uncontrollably was because 
I clasped my hands while reading in public”), Salkovskis’s (1991) hypothesis awaits continued 
empirical investigation. 
Safety Behaviors Disrupt Therapeutic Information Processing 
Information processing-based arguments (e.g., Sloan & Telch, 2002) posit that safety 
behaviors interfere with exposure by absorbing finite attentional resources. Specifically, if 
attentional focus is directed toward performing a safety behavior during an exposure, a patient 
may fail to simultaneously process that his or her fears are exaggerated (e.g., Clark, 1999).  
Kamphuis and Telch (2000) offered evidence that safety behaviors interfere with 
exposure therapy by depleting attentional resources. In their study, claustrophobic 
undergraduates were assigned to complete six 5-minute exposure trials in a claustrophobia 
chamber according to one of four possible instruction sets: a guided threat reappraisal condition 
(focus on an identified core threat belief and test the extent to which the feared outcome occurs 
during the trial), exposure with cognitive load distraction condition (complete a mental math task 
during trials), exposure with guided threat reappraisal and cognitive load condition (both sets of 
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instructions), or a no-instruction exposure control condition. Results showed that participants in 
the guided threat reappraisal condition experienced the greatest improvements at posttest and 2-
week follow-up, purportedly because they were better able to process corrective information.  
Using a similar claustrophobia exposure paradigm, Sloan and Telch (2002) compared the 
effects of threat-related safety behavior use (e.g., opening a small window in the chamber to 
bring in fresh air), guided threat reappraisal (instructions to focus on evidence that challenged 
threat-related beliefs), and no instructions on exposure outcomes. Results showed that 
participants in the guided threat reappraisal condition reported the greatest disconfirmation of 
threat estimates during a follow-up behavioral approach task (BAT). Regrettably, neither 
Kamphuis and Telch (2000) nor Sloan and Telch (2002) measured the extent to which safety 
behaviors disrupted attentional focus on belief testing. Future studies examining the extent to 
which safety behaviors siphon attention from challenging threat expectancies during an exposure 
trial are needed. 
Safety Behaviors Interfere with Inhibitory Learning 
Inhibitory learning theory implicates additional mechanisms through which safety 
behaviors might impede exposure. Specifically, safety behaviors could prevent the (a) violation 
of negative expectancies and (b) generalization of inhibitory associations across contexts. 
Although little safety behavior research has been conducted from this framework, there is some 
evidence that safety behaviors interfere with inhibitory learning processes. 
Safety behaviors prevent maximal violation of negative expectancies. The violation of 
negative expectancies is key to new learning (Bouton, 2004; Rescorla & Wagner, 1972), as this 
“mismatch” between negative predictions and noncatastrophic outcomes is thought to generate 
inhibitory associations. To illustrate, a man who minimizes the likelihood of becoming ill from 
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using a public restroom by placing a tissue barrier between his skin and bathroom surfaces might 
be less surprised by his not becoming ill than a man who touches bathroom surfaces without such 
protection. Because greater expectancy violations result in more powerful inhibitory learning 
(Baker et al., 2010), any safety behavior that attenuates the discrepancy between a patient’s 
anticipated and actual exposure outcome ought to be prevented.  
Lovibond and colleagues (2009) used a four-phase conditioning paradigm to test whether 
safety behaviors prevent the violation of negative expectancies. In the first phase, two visual 
stimuli (A and C) were followed by electric shock, yet B was not, forming “safety” associations 
with stimulus B and “danger” associations with stimuli A and C. In the second phase, 
participants could press a button to cancel the impending shock after the presentation of stimulus 
A. In the third phase, stimulus C was presented six times, never once followed by shock. During 
this phase, participants in the experimental condition could press the button after seeing stimulus 
C (i.e., perform a safety behavior), but the control group could not. In the final phase, 
participants were individually presented with stimuli A, B, and C, after which they provided 
shock expectancy ratings on a 0 (“certain no shock”) to 100 (“certain shock”) scale. Results 
showed that stimulus C shock expectancies were higher for the experimental group than the 
control group. The authors concluded that stimulus C was protected from extinction in the 
experimental group because pressing the button eliminated the “discrepancy between what is 
expected (nothing) and what actually occurs (nothing)” (Lovibond et al., 2009, p. 716). The 
clinical implications of this study are clear: safety behaviors might preclude inhibitory learning 
by preventing the maximal violation of negative expectancies for harm during exposure trials. 
Deacon and colleagues (2013) later examined the effects of safety behaviors on inhibitory 
learning during three types of interoceptive exposure (IE; exposure to feared body sensations). 
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Participants screened for fear of anxious arousal were randomized to standard IE (three IE trials 
with inter-trial relaxation periods [i.e., safety behaviors; Arch & Craske, 2011]), basic IE (three 
IE trials without safety behaviors), intensive IE (IE without safety behaviors and delivered until 
threat likelihood expectancies fell to 5%), or an expressive writing control. Consistent with the 
supposition that safety behaviors diminish inhibitory learning during exposure, participants 
receiving intensive IE experienced significantly greater improvement on primary outcomes at 
posttreatment and 1-week follow-up. Furthermore, the superior efficacy of intensive IE was fully 
mediated by greater improvement in negative expectancies and fear toleration. However, this 
study’s findings are limited by its use of a subclinical sample and single-session design.  
Safety behaviors prevent generalization of inhibitory learning. Safety behaviors could 
also interfere with long-term exposure outcome by contextualizing inhibitory associations 
(Craske et al., 2014). Research shows that not only is fear extinction less generalizable than fear 
conditioning, but it is especially vulnerable to changes in context (Bouton, 2002, 2004). 
Considering that the goal of exposure therapy is to provide patients with unconditional learned 
safety, safety behaviors should be discouraged if they restrict inhibitory learning to certain 
contexts.   
Studies examining return of fear provide support for the idea that safety behaviors 
contextualize inhibitory learning. For instance, Deacon and colleagues (2013) reported that two 
thirds of participants performing IE with safety behaviors experienced worsening of peak fear, 
fear toleration, and negative expectancies during a 1-week follow-up BAT, compared to 10% of 
participants in the intensive IE condition. Safety behavior-related return of fear has also been 
observed in the context of claustrophobia (Kamphuis & Telch, 2000; Sloan & Telch, 2002; 
Wolitzky-Taylor et al., 2008) and contamination (Goetz & Lee, 2015; Rachman, Shafran, 
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Radomsky, & Zysk, 2011). In contrast, other studies show that participants who perform safety 
behaviors during exposure maintain gains (Hood et al., 2010) and generalize learning to novel 
BATs (van den Hout, Reininghaus, van der Stap, & Engelhard, 2012). Therefore, the claim that 
safety behaviors definitively contextualize inhibitory learning is tenuous and deserves additional 
research.  
Judiciously Used Safety Behaviors Enhance Exposure Therapy 
Accumulated research demonstrates that safety behaviors do not always undermine 
exposure’s efficacy (e.g., Parrish, Radomsky, & Dugas, 2008). In fact, some argue that the 
judicious use of safety behaviors carries therapeutic advantages, such as enhancing treatment 
acceptability/tolerability and promoting approach behavior (e.g., Rachman et al., 2008). It is also 
possible that safety behaviors facilitate inhibitory learning during exposure, though research on 
the judicious use of safety behaviors from this perspective is scant.  
Safety Behaviors Enhance Exposure’s Acceptability and Tolerability 
Citing unacceptable treatment refusal and dropout rates, some experts have argued that 
the judicious use of safety behaviors might increase the likelihood that patients consent to and 
complete exposure therapy (Rachman et al., 2008). To test the possibility that strategically 
incorporating safety behaviors enhances treatment acceptability/tolerability without diminishing 
its efficacy, Milosevic and Radomsky (2013a) compared perceptions of exposure therapy among 
a sample of CBT-naïve undergraduates and anxious community members. Participants read one 
of four vignettes: (a) exposure therapy with a cognitive (belief testing) rationale with the 
judicious use of safety behaviors; (b) exposure therapy with a cognitive rationale and immediate 
response prevention, (c) exposure therapy with a fear reduction (i.e., habituation) rationale with 
the judicious use of safety behaviors, or (d) exposure therapy with a habituation rationale and 
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immediate response prevention. Results showed that a cognitive rationale including the judicious 
use of safety behaviors received the highest endorsement, acceptability, and predicted adherence 
ratings and lower ratings of anticipated discomfort in both groups. Similar findings emerged in 
another undergraduate sample (Levy, Senn, & Radomsky, 2014). 
Although these studies provide preliminary evidence that the judicious use of safety 
behaviors enhances treatment acceptability, they are limited by their vignette design and frequent 
use of nonclinical samples. Most exposure protocols outline at least one session devoted to 
providing psychoeducation and a persuasive treatment rationale before initiating exposure and 
response prevention in order to increase acceptability of an objectively challenging treatment 
(e.g., Abramowitz, 2013; Barlow et al., 2011). Given that the vignettes in the aforementioned 
studies did not include this degree of psychoeducation, it is unclear whether the brief 
descriptions used in these studies elicited ecologically valid treatment perceptions.  
To address some of these limitations, Levy and Radomsky (2014) examined the 
acceptability of contamination exposure delivered with or without instructions to use rubber 
gloves. Results showed that nonclinical undergraduates using gloves provided higher treatment 
acceptability and anticipated adherence ratings after the exposure than those in the no safety 
behavior condition. However, because no rationale was offered regarding the use of gloves—and 
participants conducted only a single exposure session—it is unclear whether the judicious use of 
safety behavior might enhance treatment acceptability, adherence, or outcomes among treatment-
seeking patients receiving a full course of exposure therapy with adequate psychoeducation. 
In contrast to the above findings, other studies found that individuals conducting 
exposure with or without safety behaviors rated interventions as equally acceptable (Deacon et 
al., 2012, 2013; Deacon, Sy, Lickel, & Nelson, 2010; Milosevic & Radomsky, 2013b). 
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Moreover, it is important to delineate treatment acceptability and treatment likability, as anxious 
individuals are able to tolerate, accept and benefit from treatment they nevertheless rate as 
slightly aversive (Deacon et al., 2013). Additional research examining safety behaviors’ effects 
on treatment acceptability/tolerability in a more ecologically valid context would be useful. 
Safety Behaviors Promote Approach Behavior 
The judicious use of safety behaviors could also facilitate new learning by (a) 
accelerating the rate at which patients approach exposure stimuli and/or (b) promoting closer 
approach to exposure stimuli (e.g., Hood et al., 2010). For instance, Milosevic and Radomsky 
(2008) studied snake fearful undergraduates randomized to a 45-minute exposure session with or 
without safety gear (e.g., gloves, goggles), assessing behavioral approach in 5-minute intervals 
and at 10 minutes posttreatment. Results showed that although there were no significant 
differences in BAT distance between groups at the end of treatment or at 10 minutes 
posttreatment, participants in the safety behavior condition were able to get significantly closer 
to the snake during the first 15 minutes of the exposure. This pattern of findings was replicated 
by Milosevic and Radomsky (2013b), who showed that spider fearful participants encouraged to 
use similar safety gear approached a spider more closely during the first five minutes than did 
participants without safety gear.  
Hood and colleagues (2010) also examined group differences in behavioral approach 
between spider fearful undergraduates randomized to a 30-minute exposure either with or 
without safety behaviors (e.g., gloves, hat, long-sleeved clothing). Results showed that although 
participants using safety gear approached the spider more quickly than those in the exposure only 
group, approach distance was comparable between groups by the end of the exposure session and 
superior among participants forgoing safety gear at follow-up.  
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Two studies examined the effects of safety behaviors on behavioral approach in a 
contamination context. Levy and Radomsky (2014) showed that nonclinical undergraduates 
randomized to exposure with gloves completed significantly more contamination BAT steps 
(ranging from “approach and smell from within three feet” to “touch with both hands, then rub 
together”) compared to those conducting exposure without gloves. Differentiating safety 
behaviors based on function, Goetz and Lee (2015) compared the effects of using preventative 
safety behaviors (using a tissue as a barrier between skin and contaminants), restorative safety 
behaviors (using hand sanitizer after each touch with a contaminant), and no safety behaviors 
during exposure. Results showed that the restorative safety behavior group completed more 
posttreatment BAT steps than the other groups, who did not significantly differ from each other. 
However, the use of nonclinical samples, identical BAT and treatment stimuli, and lack of 
follow-up assessments limit these studies’ findings. 
Not all research has found that safety behaviors facilitate approach toward feared stimuli 
(Deacon et al., 2010; Hood et al., 2010; Milosevic & Radomsky, 2008, 2013b). These mixed 
findings are puzzling and challenge the argument that safety behaviors enhance behavioral 
outcomes. Considering that previous research largely relied on single-session designs and limited 
follow-up assessments, a longitudinal study on this topic is needed.  
Safety Behaviors Facilitate Inhibitory Learning  
The majority of safety behavior research stems from cognitive or emotional processing 
accounts of exposure. As such, there is a dearth of research on how the judicious use of safety 
behaviors may optimize mechanisms related to inhibitory learning. Nevertheless, existing 
research does point to circumstances in which the judicious use of safety behaviors might 
facilitate inhibitory learning during exposure.  
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Safety behaviors allow for the violation of negative expectancies. It has been argued 
that safety behaviors motivate patients to engage in exposure tasks they are otherwise unwilling 
to attempt (van den Hout et al., 2012). It follows that safety behaviors allow for opportunities to 
violate negative expectancies by stimulating patients to conduct more (or more challenging) 
exposures. Another way safety behaviors may help generate inhibitory associations is by 
strategically guaranteeing positive exposure outcomes. Specifically, if a feared situation (e.g., 
drowning one’s newborn) is impossible in the context of concurrent safety behaviors (e.g., 
requiring a spouse’s presence while bathing the newborn), then an inhibitory association (e.g., “I 
won’t drown my baby”) can be made. This argument is consistent with the work of Bandura and 
colleagues (1974, p. 57), who noted that the “arrangement of protective conditions that reduce 
the likelihood of feared consequences” may expedite anxiety treatment. 
No experimental work has shown that the judicious use of safety behaviors optimizes 
inhibitory learning via the violation of negative expectancies during exposure. However, studies 
that found significant differences in behavioral approach as a function of safety behavior use do 
offer indirect support for this idea (e.g., Goetz & Lee, 2015). Empirical research directly testing 
the effect of safety behaviors on threat expectancies and expectancy violations is needed.  
Safety behaviors promote generalization of inhibitory learning. It is understood that 
exposures should be conducted in various contexts to generalize learning (Bouton, 2002). It 
follows that if a patient is unwilling to perform exposures in novel (i.e., more difficult) contexts 
without using safety behaviors, inhibitory learning cannot generalize. Although not demonstrated 
in published research to date, it is possible that safety behaviors help decontextualize inhibitory 
associations by motivating patients to conduct exposures in multiple contexts. 
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Rachman and colleagues (2008, p. 171) suggested that “when problems are encountered 
in transferring the reduction of fear from the clinic to the patient’s home, generalization can be 
facilitated by the use of safety behavior.” For example, if a woman with social phobia will 
engage in “small talk” with neighbors without advance mental rehearsal, but is reluctant to 
engage in spontaneous conversation with her work supervisor, she could be encouraged to 
mentally rehearse her conversation before speaking with her supervisor to help her test her social 
fears in a new context. In this way, safety behavior might decontextualize inhibitory associations 
by making novel contexts less threatening. To fully generalize inhibitory associations, however, 
exposure tasks should eventually be completed without the safety behaviors initially required 
(Craske et al., 2014). Indeed, the eventual fading of safety behaviors over treatment is consistent 
with the judicious use of safety behaviors as originally formulated (Rachman et al., 2008). 
Limitations of Previous Safety Behavior Research 
The controversial role of safety behaviors during exposure therapy has garnered 
substantial research attention, yet empirical findings are mixed (for reviews, see Blakey & 
Abramowitz, 2016; Goetz, Davine, Siwiec, & Lee, 2016; Meulders et al., 2016). Moreover, 
findings from previous studies are subject to a number of limitations that prevent making 
definitive conclusions. For example, many experiments prescribed very brief exposure trials, 
even though most treatment protocols recommend prolonged trials (e.g., at least 30 minutes; 
Abramowitz, Deacon, & Whiteside, 2011). Similarly, whereas a course of exposure therapy in 
naturalistic settings involves multiple therapy sessions, safety behavior-related experiments 
conducted to date relied on single-session analogue interventions. This is problematic given that 
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single-session interventions threaten the ecological validity of study findings.1 More importantly, 
single-session experiments also preclude examination of the judicious use of safety behaviors as 
originally defined: the careful and strategic use of safety behavior applied “in a limited manner 
and only for a limited period, especially in the early stages of treatment” (Rachman et al., 2008, 
pp. 171). Although one study examined the relative effects of participant- versus experimenter-
initiated safety behavior fading in a sample of undergraduates with subclinical contamination 
fear, fading occurred over the course of a single session, which involved 20 consecutive trials of 
touching a contaminated object (e.g., a partly filled garbage basket) with 30-second inter-trial 
delay periods (Levy & Radomsky, 2016). Longitudinal studies allowing for the fading of safety 
behaviors over multiple exposure sessions would afford a more precise test of the judicious use 
of safety behaviors approach, which could better inform clinical practice.  
Another limitation of related work regards the method of outcome assessment in previous 
studies. Accumulated research shows that fear reduction (i.e., habituation) during exposure is not 
a reliable predictor of long-term outcome (e.g., Baker et al., 2010; Craske et al., 2008); however, 
most previous safety behavior studies relied on pre- to post-exposure fear ratings as primary 
outcome measures (for notable exceptions, see Deacon, Kemp, et al., 2013; Milosevic & 
Radomsky, 2013b). Studies using multi-method assessment of multiple indices of exposure 
success might better explicate the consequences of using safety behaviors during exposure 
(Campbell & Fiske, 1959). Measuring processes related to inhibitory learning (e.g., negative 
expectancies for harm) would further enhance our understanding of if—and how—safety 
behaviors influence exposure outcomes.  
                                                             
1 Briefer interventions may be more appropriate in the context of specific phobia, in light of numerous controlled 
studies demonstrating the efficacy of intensive exposure treatments for this condition (Zlomke & Davis, 2008). 
18 
Relatedly, despite the importance of assessing the durability of extinction learning 
beyond immediate posttreatment (Craske et al., 2008, 2014), most studies conducted to date 
lacked follow-up assessment or relied on very brief follow-up periods (e.g., 10 minutes; 
Milosevic & Radomsky, 2008). Although practical constraints (e.g., limited financial resources) 
are valid obstacles in experimental research, lack of sufficient long-term assessment data 
nevertheless poses a limitation that ought to be addressed in future studies. To enhance the 
validity and clinical utility of safety behavior research, studies including a follow-up period of at 
least one month would be helpful (Maruish, 2004).  
The judicious use of safety behaviors is a controversial thesis; moreover, practicing 
therapists are left without clear direction, given that inconsistent study findings carry 
contradictory clinical implications. Further complicating matters, experimental studies of the 
effects of safety behaviors during exposure are methodologically limited and little research 
speaks to the ways in which safety behaviors influence inhibitory learning during treatment. 
Given the growing popularity of the inhibitory learning model of exposure therapy and the 
possibility for the judicious use of safety behaviors to either enhance or undermine exposure’s 
efficacy, a longitudinal study including multimethod assessment and measures of inhibitory 
learning processes is needed. 
Study Aims and Hypotheses 
The current randomized controlled trial was designed to examine the relative efficacy of 
traditional exposure with response prevention (E/RP) and the experimental exposure with the 
judicious use of safety behaviors (E/JU) in a sample of adults with DSM-5 spider phobia. In 
order to extend and address the limitations of previous related research, special methodological 
consideration was given to: (a) adhering to the fundamental definition of the judicious use of 
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safety behaviors (i.e., strategically incorporating safety behaviors at the start of treatment but 
eventually fading them out; Rachman et al., 2008), (b) improving assessment methodology (i.e., 
using multi-method assessment of several indices of exposure success and gathering long-term 
follow-up data), (c) enhancing ecological validity (e.g., extending the number and duration of 
exposures), and (d) incorporating measures of cognitive-behavioral processes thought to underlie 
inhibitory learning. In light of the research reviewed above, several hypotheses were made 
regarding the short- and long-term treatment effects:  
1. Primary outcomes: We predicted that the E/RP participants would demonstrate greater 
improvement in spider phobia than the E/JU participants along self-report and behavioral 
symptom measures at follow-up (but not posttreatment).  
2. Secondary outcomes: We predicted that treatment acceptability/tolerability ratings would 
be higher for E/JU participants, relative to E/RP participants, before beginning exposures 
(but not at posttreatment or follow-up). We also predicted that the E/RP participants, 
relative to E/JU participants, would report lower peak distress and greater distress 
tolerance during an in vivo behavioral task at follow-up (but not at posttreatment). 
3. Exposure process variables: Exploratory analyses were conducted to compare self-
reported (a) negative expectancies, (b) attentional focus, and (c) exposure outcome 
attributions (i.e., attributions of safety) across the three exposure trials, as well as to 
examine the (d) relative rate of behavioral approach and exposure goal completion 
between treatment conditions. Although previous research findings are mixed, conceptual 
accounts (Craske et al., 2008, 2014; Hood et al., 2010; Salkovskis, 1991; Sloan & Telch, 
2002) suggest that (a) E/RP participants would report greater negative expectancies for 
harm across exposure trials relative to E/JU participants, (b) attentional focus toward 
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belief testing would be greater across exposure trials for E/RP participants relative to 
E/JU participants, (c) E/JU participants would make more safety behavior-related 
exposure outcome attributions than would be expected by chance, and (d) E/JU 
participants would be more likely to reach their exposure goal and would reach their 
exposure goal more quickly than the E/RP participants. 
Method 
Participants 
A sample of 60 adults with DSM-5 spider phobia participated in this study. The target 
enrollment was determined by a-priori power analyses (G*Power 3.1.9.2; Faul, Erdfelder, 
Buchner, & Lang, 2009) calculating the sample size needed to provide 80% power to detect a 
small to medium hypothesized effect at α = .05 using a repeated measures ANOVA test. 
Previous studies using similar experimental paradigms have used comparable sample sizes 
(ranging from 11 to 63 per condition; Powers, Smits, & Telch, 2004; Sy, Dixon, Lickel, Nelson, 
& Deacon, 2011; Wolitzky & Telch, 2009). The sample was mostly (85.0%, n = 51) female and 
had a mean age of 31.52 years (SD = 13.10). Most participants (68.3%, n = 41) self-identified as 
White or Caucasian, 20.0% (n = 12) self-identified as Black or African American, 6.7% (n = 4) 
self-identified as Asian or Asian American, and 3.3% (n = 2) self-identified with another racial 
background. Two participants (3.3%) self-identified as Hispanic/Latino/Latina.  
Participants were recruited to participate in this study (advertised as “Overcome Your 
Spider Phobia”) between September 15, 2016, and July 31, 2017. Participants were recruited 
from the Raleigh-Durham-Chapel Hill community via flyers, a clinical research recruitment 
website (https://jointheconquest.org/), and email listserv advertisements. Treatment was provided 
at no cost and participants were compensated with parking reimbursement and $20 cash at the 
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follow-up visit. Eligibility criteria included (a) at least 18 years of age, (b) presence of DSM-5 
spider phobia, (c) English fluency, and (d) willingness to attend and audiotape all study sessions. 
Interested individuals were deemed ineligible if they (a) completed 10 or more steps on the 
pretreatment BAT or reported (b) spider or bee allergies, (c) a previous trial of exposure-based 
CBT for any anxiety problem, (d) current alcohol or substance use disorder, (e) lifetime 
symptoms of mania or psychosis, or (f) current suicidal ideation. 
Trial Design and Randomization 
 This study followed a two-arm, parallel-group randomized controlled study design. 
Participants were randomized to either E/JU or E/RP. Randomization was achieved prior to 
initial participant recruitment via a random number generator (http://www.random.org) with the 
condition that an equal number of participants (n = 30) be randomized to each condition. Pre-
determined condition allocation was listed in an Excel spreadsheet and concealed with a cell 
masking color. The study’s principal investigator screened participants, enrolled participants, and 
assigned participants to study interventions by listing participant ID codes on the condition 
assignment Excel spreadsheet (that was already masked to conceal condition assignment) in the 
order in which participants completed the initial phone screening. Only the participant’s therapist 
viewed the allocated condition by temporarily lifting the cell mask immediately before the first 
treatment session.  
Procedure 
Interested individuals contacted the principal investigator via email to schedule an initial 
phone screening. Participants who met initial eligibility criteria during the phone screen were 
scheduled for a pretreatment (PRE) assessment and initial treatment session. Attendees met a 
trained undergraduate research assistant, who was blind to study hypotheses and participants’ 
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assigned conditions, to provide informed consent and complete the PRE assessment (see 
“Measures,” below). Individuals who completed at least ten steps on the BAT at PRE were 
deemed ineligible, provided with referral information and the principal investigator’s contact 
information, and dismissed. Individuals who completed fewer than ten steps on the BAT at PRE 
were enrolled in the study (i.e., allocated to the pre-determined condition). Immediately after the 
PRE, the participant’s therapist delivered Session 1 of either E/RP or E/JU. Immediately after 
Session 4, participants met a condition- and hypothesis-blind research assistant to complete the 
posttreatment (POST) assessment. Shortly after the POST assessment, the principal investigator 
contacted the participant to schedule the 1-month follow-up (F/U) visit, during which time the 
participant completed a final assessment with a condition- and hypothesis-blind research 
assistant, was compensated, and debriefed. This study was approved by the university’s 
Institutional Review Board and was registered at http://www.clinicaltrials.gov (NCT03233113).  
Intervention and Materials 
Procedures common to both conditions. Participants in both conditions received four 
twice-weekly, hour-long, individual treatment sessions with a trained exposure therapist. The 
principal investigator wrote the condition-specific treatment manuals (see Supplemental 
Materials), which were based on evidence-based exposure programs for anxiety and phobias (in 
order to enhance external validity; Abramowitz et al., 2011; Antony, Craske, & Barlow, 1995) 
clinical recommendations for how to apply inhibitory learning theory to exposure therapy 
(Craske et al., 2014), and the seminal publication on the judicious use of safety behaviors 
(Rachman et al., 2008). The treatment programs were approved by E/RP and E/JU experts (Drs. 
Jonathan Abramowitz and Adam Radomsky, respectively). 
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Session 1 involved functional assessment, psychoeducation, presentation of the treatment 
rationale, and treatment planning. First, the therapist conducted a semi-structured interview to 
understand the maladaptive beliefs, triggers, appraisals, anxiety responses, and safety behaviors 
associated with the participant’s primary spider-related belief according to a cognitive-behavioral 
model of clinical anxiety. Next, the therapist provided a rationale for either E/RP or E/JU. In the 
E/RP condition, participants were told that safety behaviors maintain spider phobia and interfere 
with phobia treatment because they (a) prevent disconfirmation of mistaken core beliefs and (b) 
absorb attentional resources necessary to achieve corrective learning. In the E/JU condition, 
participants were told that safety behaviors alleviate the experience of spider phobia and enhance 
phobia treatment because they (a) make the anxiety-provoking situation less distressing and (b) 
enhance one’s ability to remain in the phobic situation for longer or at a closer distance. 
Therapists explained to all participants that covert/mental safety behaviors (e.g., distraction, 
thought-stopping) interfered with exposure treatment and explicitly discouraged participants 
from engaging in any such strategies. Next, participants identified the (a) primary core belief 
(i.e., negative expectancy) to be tested during all exposures and (b) the exposure task to be 
attempted at the next three sessions. To maximize internal consistency, the same task was 
conducted to test the same negative expectancy at Sessions 2-4 (participants did not create a fear 
hierarchy with the therapist or design multiple exposures to test different expectancies). 
Sessions 2-4 included a review of the model of spider phobia and treatment rationale, a 
review of the previous session’s exposure (at Sessions 3 and 4), condition-specific reminders 
about how to prevent versus strategically use safety behaviors during the session’s exposure, a 
30-minute in vivo exposure trial involving a live tarantula, and post-exposure processing. Session 
4 also involved a discussion of relapse prevention strategies, including psychoeducation about 
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the difference between a lapse (i.e., a temporary return of some symptoms) and a relapse (i.e., a 
complete return of all phobia symptoms). To maximize internal consistency, participants were 
not instructed to conduct additional exposure tasks as “homework” between sessions or during 
the follow-up period. 
Procedures specific to E/JU. Consistent with Rachman and colleagues’ (2008) 
definition of the judicious use of safety behaviors, participants were told at Session 1 that they 
would strategically use two safety behaviors at the first exposure, one safety behavior during the 
second exposure, and no safety behaviors during the third exposure. After identifying the 
exposure task to be attempted at the next three sessions, therapists used the Safety Behavior 
Selection Form (see “Measures,” below) to help E/JU participants choose their preferred safety 
behaviors. To balance internal consistency and ecological validity, the current study incorporated 
semi-ideographic safety behaviors. Specifically, E/JU participants chose two of eight available 
items often used in safety behavior research: eye goggles, a dental visor face shield, a long 
chemistry apron, a long-sleeve rain jacket, short work gloves, long chemistry gloves, boot/shoe 
covers, or a 12” clear plastic shield. To minimize risk of contamination between conditions, 
participants were told that they must use the allocated number of safety behaviors at each 
session. All participants complied with safety behavior instructions across all exposure trials. 
Treatment setting and providers. Data were collected at a large university in the 
southeastern United States. Three advanced clinical psychology graduate students and two post-
baccalaureate research assistants (all female) served as therapists on this study. All therapists 
underwent a five-week standardized training program with the principal investigator, which 
involved didactic readings (Abramowitz, 2013; Antony et al., 1995; Olatunji, Deacon, & 
Abramowitz, 2009; Rachman et al., 2008; Telch & Lancaster, 2012), group seminars, and 
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experiential role-plays. Therapists had to demonstrate competency in specific and non-specific 
clinical skills via audio/video recorded role-play exercises with pilot participants before 
delivering treatment to enrolled study participants.  
Phobic stimuli. Two visually distinct tarantulas were used in this study: an Arizona 
blonde (Aphonopelma chalcodes) and rose hair (Grammostola rosea) tarantula. To maximize 
internal consistency, participants conducted exposures to the same tarantula for all treatment 
sessions. To enhance external validity, the opposite (i.e., novel) tarantula was used for all 
assessments. To minimize the potentially confounding effect of tarantula breed on study 
findings, tarantulas were counterbalanced so that approximately half of the sample conducted 
exposures with each tarantula. Tarantulas were housed in separate terrariums, which were hidden 
from participant view when not in use. 
Treatment fidelity. Based on guidelines published by the Treatment Fidelity Workgroup 
of the National Institutes of Health Behavior Change Consortium (Bellg et al., 2004; Borrelli et 
al., 2005), several methodological strategies were used to enhance and monitor the reliability and 
validity of the study’s intervention. This involved incorporating multiple specific 
recommendations during study design, therapist training, treatment delivery, treatment receipt, 
and treatment skills enactment, where applicable (see Appendix A).  
In addition, two hypothesis-blind undergraduate research assistants coded 15% (n = 36) 
of the recorded treatment tapes, which is in line with Lombard and colleagues’ (2002) 
recommendations to evaluate a minimum 10% of treatment units. Session recordings were 
randomly selected via a random number generator (http://www.random.org), with the condition 
that an equal number of tapes be coded for each session number (n = 9) and treatment condition 
(n = 13). Twelve items assessing treatment process (e.g., interpersonal effectiveness) were 
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derived from the Beck Cognitive Therapy Scale (Young & Beck, 1980). An additional 9 to 17 
items assessing treatment content mapped onto the study treatment manuals’ session-specific 
content headings. All items were rated on a 0 (poor) to 6 (excellent) scale, or else marked as “not 
applicable” (i.e., specific component was not delivered). Fidelity coders were trained by the 
principal investigator and had to demonstrate 100% simple agreement with the principal 
investigator’s fidelity ratings of four session recordings (one for each session number) before 
coding tapes independently. Interrater agreement was defined as providing identical scores for 
nominal ratings and a difference score of ≤ 1 for continuous ratings. Interrater reliability of the 
current study’s fidelity coders was excellent (simple agreement 98.38%; agreement on 1877 of 




Fear of Spiders Questionnaire (FSQ; Szymanski & O’Donohue, 1995). The FSQ is an 
18-item self-report measure of spider phobia. Participants rate their agreement with each 
statement (e.g., “If I saw a spider now, I would think it will harm me”) on a scale of 0 (totally 
disagree) to 7 (totally agree). Possible total scores range from 0 to 126, such that higher scores 
indicate greater spider fear. The FSQ was administered at the PRE, POST, and F/U assessments. 
The FSQ has shown high internal consistency, high test-retest reliability, and adequate 
convergent validity in previous work (Muris & Merckelbach, 1996; Szymanski & O’Donohue, 
1995). Internal consistency was excellent in the current sample (αPRE = 0.91, αPOST = 0.95, αF/U = 
0.95). 
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Behavioral Approach Task (BAT). A tarantula BAT inspired by spider-related BATs 
used in previous research (e.g., Olatunji, Huijding, De Jong, & Smits, 2011; Woody, McLean, & 
Klassen, 2005) served as the behavioral outcome variable in this study and was administered 
after self-report measures at the PRE, POST, and F/U assessments. The BAT included 13 rank-
ordered steps ranging from standing at the opposite end of a room containing a tarantula 
enclosed in a closed terrarium covered with a sheet to allowing the tarantula to crawl up one’s 
bare arm. A participant must have held a BAT step for 10 consecutive seconds for the step to 
count as completed. BAT scores were recorded as the number of the highest step completed. 
Total scores range 0 to 13, with higher scores indicating greater behavioral approach.  
Secondary outcomes. 
Treatment Acceptability and Adherence Scale (TAAS; Milosevic, Levy, Alcolado, & 
Radomsky, 2015). The TAAS is a 10-item self-report measure of treatment acceptability and 
tolerability. Participants rate each statement (e.g., “If I participated in this treatment, I would be 
able to adhere to its requirements”) on a 1 (disagree strongly) to 7 (agree strongly) scale. Six 
items are reverse-scored such that possible total scores range from 10 to 70, with higher scores 
indicating greater treatment acceptability/tolerability. The TAAS was administered at the end of 
Session 1 (after delivery of the treatment rationale), as well as at the POST and F/U assessments. 
Items were slightly modified at POST and F/U to reflect the point at which the participants 
completed the scale (e.g., “I was able to adhere to the requirements of this treatment”), as 
recommended by the scale authors. Internal consistency was acceptable in the current sample 
(αS1 = 0.70, αPOST = 0.71, αF/U = 0.74). 
Peak BAT distress. Immediately after completing each step of the BAT (at each 
assessment), participants were asked to verbally and separately report their anxiety and disgust 
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using a scale of 0 (not at all) to 10 (absolutely/maximally). The highest self-reported values were 
separately recorded as peak BAT anxiety and peak BAT disgust, which were summed together to 
form a single peak BAT distress value (possible distress scores range 0 to 20, with higher scores 
indicating greater peak distress). 
In vivo BAT distress tolerance. Immediately after completing the BAT (at each 
assessment), participants were asked: “Regardless of how intense your distress was, how well 
did you tolerate your distress? That is, how well were you able to manage whatever emotions 
and sensations came up during the exercise, even if they were very strong?” Participants verbally 
reported ratings of in vivo distress tolerance using a 0 (not at all able to tolerate my distress) to 
10 (completely able to tolerate my distress) scale.  
Exposure process variables.  
Negative expectancy for harm. Immediately prior to beginning each exposure, 
participants were asked to verbally report how strongly they believed that their negative 
prediction for harm (i.e., the primary phobic belief being tested during the exposure) would 
occur, using a scale of 0 (0% certain it will occur) to 100 (100% certain it will occur). Negative 
expectancy ratings from all three exposures were averaged to yield a single summary score. 
Attentional focus on challenging negative predictions. At the halfway point (15-minute 
mark) of each exposure, participants were asked to verbally report how much attention they were 
paying toward testing their negative prediction for harm, versus letting their attention go toward 
doing or thinking about something else, using a scale of 0 (paying 0% attention to testing belief) 
to 100 (paying 100% attention to testing belief). Attentional focus ratings from all three 
exposures were averaged to yield a single summary score. 
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Attributions for exposure outcome. Immediately after each exposure, participants were 
asked to verbally self-report their attribution for the exposure’s outcome. Specifically, the 
therapist asked: “you predicted that [negative prediction] would happen as a result of this 
exposure, but [actual outcome] happened instead. What do you attribute this to?” Responses 
were recorded verbatim and later coded to denote the number of times E/JU participants’ 
responses included an attribution that was explicitly related to the selected safety behaviors (e.g., 
“the spider didn’t bite me because I was wearing gloves”).  
Behavioral approach across exposure trials. All exposure session recordings were coded 
to compare the rate of behavioral approach and exposure goal completion between treatment 
conditions. Nominal (“dummy”) coding was used to denote whether the exposure goal identified 
at Session 1 was met during at any point during treatment; ordinal coding was used to indicate 
whether participants first met their goal at Session 2, Session 3, or Session 4.  
Diagnostic screening measures.   
Anxiety Disorders Interview Schedule for DSM-5 (ADIS-5; Brown & Barlow, 2014). 
The ADIS-5 is a semi-structured standardized clinical interview that assesses current anxiety-
related diagnoses according to DSM-5 criteria. The specific phobia module was administered to 
all interested individuals during the initial phone screening to determine the presence of DSM-5 
spider phobia. This module assesses specific symptoms as well as interference and distress, 
which are rated separately on a 0 (none) to 8 (very severe) scale. Individuals must have met 
DSM-5 (APA, 2013) criteria for specific phobia and endorsed a score of at least four (moderate 
fear/sometimes avoids) on the distress and/or interference item in order to be considered eligible 
to participate. The phone screener consulted the study’s licensed clinical supervisor to confirm 
that the interested individual met diagnostic criteria before scheduling the PRE assessment. 
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Because the ADIS-5 was not used as an outcome measure (i.e., it was only used as an initial 
screening tool), diagnostic reliability was not evaluated in the current study. 
Mini International Neuropsychiatric Interview for DSM-5 (MINI; Sheehan, 2015). The 
MINI is a brief structured interview that assesses several major DSM-5 disorders. The manic and 
hypomanic episodes, alcohol use disorder, substance use disorder, and psychotic disorders and 
mood disorder with psychotic features modules were administered during the initial phone 
screening to determine initial eligibility to participate. Because the MINI was not used as a 
dependent measure (i.e., it was only used as an initial screening tool), diagnostic reliability was 
not evaluated in the current study. 
Safety Behavior Selection Form. After identifying the exposure task to be attempted 
during treatment, participants in the E/JU condition were shown a set of available safety items, 
given a description of the item’s function (e.g., “this face shield creates a barrier between your 
face and the spider”), and then asked to verbally provide a rating of the perceived helpfulness of 
each item on a scale from 0 (not at all helpful) to 10 (most helpful). The item that received the 
highest rating was used during the first and second exposure tasks; the second-highest rated item 
was used during the first exposure only. In cases where the two highest-rated items were 
redundant (e.g., long chemistry gloves and short work gloves), the first-choice item was selected 
to be used during the first two exposures and the therapist worked with the participant to find the 
next most helpful item that the participant wished to use at the first exposure only. Descriptive 
data for this measure are presented in Table 1. 
Data Analytic Strategy 
 Primary outcome analyses. To test for group differences in spider phobia symptoms, 
two separate 2 (condition) x 3 (time) mixed factorial (i.e., repeated measures) ANOVAs were 
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conducted, with condition entered as the between-subjects factor, time entered as the within-
subjects factor, and FSQ and BAT scores entered as the individual dependent variables.  
 Secondary outcome analyses. To examine relative treatment acceptability/tolerability, a 
2 (condition) x 3 (time) mixed factorial ANOVA was conducted, with TAAS scores entered as 
the dependent variable. To test for group differences in BAT-related emotional experiences, two 
separate 2 (condition) x 3 (time) mixed factorial ANOVAs were conducted, with peak BAT 
distress and in vivo BAT distress tolerance scores entered as the individual dependent variables.  
Exploratory analyses. Two separate independent samples t-tests were used to examine 
group differences in mean (a) negative expectancies for harm and (b) attentional focus on 
challenging negative predictions across exposures. A one-sample t-test was used to examine 
whether the mean number of safety behavior-related exposure outcome attributions reported by 
E/JU participants was significantly non-zero. Finally, we planned to conduct two chi-square tests 
of independence to (a) examine differences in exposure goal completion as a function of 
treatment condition and (b) compare the relative rate of exposure goal completion between E/RP 
and E/JU conditions.  
Results 
Treatment Dropout  
Figure 1 displays the CONSORT participant flow diagram. Three participants (5%; two 
from E/RP and one from E/JU) dropped out of treatment. One participant (E/RP) requested a 
change to the treatment schedule that could not be accommodated by study personnel; reasons 
for the other two participants’ discontinuation are unknown. The three treatment non-completers 
did not significantly differ from the completers on any baseline measure (all ps > .05). Given the 
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low dropout rate, analyses reported below were conducted using the completer sample only.2 
Primary and secondary outcome descriptive data are presented in Table 2.  
Primary Outcomes  
 Self-reported spider phobia symptom severity (FSQ). A 2 (condition) x 3 (time) 
mixed factorial ANOVA was used to examine the effect of treatment condition on FSQ scores. 
Results showed that although there was a significant main effect of time, F(2, 110) = 254.20, p < 
.001, η2 = .82, there was no significant main effect of condition, F(1, 55) = 1.62, p = .208, η2 = 
.03, and no significant interaction between time and condition, F(2, 110) = 1.27, p = .285, η2 = 
.02. Follow-up paired samples t-tests indicated that across conditions (i.e., in the entire sample), 
FSQ scores significantly improved from PRE (M = 90.19, SD = 19.80) to POST (M = 28.56, SD 
= 21.10), t(56) = 17.25, p < .001, d = 2.28, and from PRE to F/U (M = 30.32, SD = 21.87), t(56) 
= 16.10, p < .001, d = 2.13, but not from POST to F/U, t(56) = 1.08, p = .287, d = 0.14. 
In vivo behavioral approach (BAT steps). A 2 (condition) x 3 (time) mixed factorial 
ANOVA was used to examine the effect of treatment condition on completed BAT steps. Results 
showed that although there was a significant main effect of time, F(2, 110) = 247.52, p < .001, η2 
= .82, there was no significant main effect of condition, F(1, 55) = 0.011, p = .919, η2 < .001, and 
no significant interaction between time and condition, F(2, 110) = 0.264, p = .769, η2 = .01. 
Follow-up paired samples t-tests indicated that across conditions, BAT scores significantly 
improved from PRE (M = 6.11, SD = 2.80) to POST (M = 11.44, SD = 2.21), t(56) = 16.42, p < 
.001, d = 2.18, and from PRE to F/U (M = 11.61, SD = 2.14), t(56) = 16.31, p < .001, d = 2.16, 
but not from POST to F/U, t(56) = 1.43, p = .159, d = 0.19. 
                                                             
2 Intent-to-treat analyses using a “last observation carried forward” imputation approach produced the same pattern 
of findings. 
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Secondary Outcomes  
Treatment acceptability and tolerability. A 2 (condition) x 3 (time) mixed factorial 
ANOVA was used to examine the effect of treatment condition on TAAS ratings. Results 
showed that although there was a significant main effect of time, F(2, 110) = 115.02, p < .001, η2 
= .68, there was no significant main effect of condition, F(1, 55) = 0.287, p = .594, η2 = .01, and 
no significant interaction between time and condition, F(2, 110) = 0.556, p = .575, η2 = .01. 
Follow-up paired-samples t-tests indicated that across conditions, TAAS scores were 
significantly higher at POST (M = 62.11, SD = 6.17) relative to PRE (M = 53.63, SD = 6.34), 
t(56) = 13.59, p < .001, d = 1.89, and at F/U (M = 61.33, SD = 6.88) relative to PRE, t(56) = 
10.82, p < .001, d = 1.43, but not at F/U relative to POST, t(56) = 1.57, p = .123, d = 0.21. 
Peak BAT distress. A 2 (condition) x 3 (time) mixed factorial ANOVA was used to 
examine the effect of treatment condition on peak distress ratings during the BAT assessments. 
Results showed that although there was a significant effect of time, F(2, 106) = 44.47, p < .001, 
η2 = .46, there was no significant main effect of condition, F(1, 53) = 0.249, p = .620, η2 = .01, 
and no significant interaction between time and condition, F(2, 106) = 0.772, p = .465, η2 = .01. 
Follow-up paired samples t-tests indicated that across conditions, peak BAT distress ratings were 
significantly lower at POST (M = 7.22, SD = 5.90) relative to PRE (M = 12.98, SD = 5.07), t(54) 
= 6.88, p < .001, d = 0.93, and at F/U (M = 7.09, SD = 5.41) relative to PRE, t(54) = 7.42, p < 
.001, d = 1.00, but not at F/U relative to POST, t(54) = 0.729, p = .469, d = 0.10. 
In vivo BAT distress tolerance. A 2 (condition) x 3 (time) mixed factorial ANOVA was 
used to examine the effect of treatment condition on distress tolerance ratings during the BAT 
assessments. Results showed that although there was a significant main effect of time, F(2, 104) 
= 57.89, p < .001, η2 = .53, there was no significant main effect of condition, F(1, 52) = 0.774, p 
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= .383, η2 = .02, and no significant interaction between time and condition, F(2, 104) = 0.859, p 
= .426, η2 = .02. Follow-up paired samples t-tests indicated that across conditions, BAT distress 
tolerance scores were significantly higher at POST (M = 9.13, SD = 1.32) relative to PRE (M = 
6.30, SD = 2.63), t(53) = 7.801, p < .001, d = 1.06, and at F/U (M = 9.06, SD = 1.30) relative to 
PRE, t(53) = 7.80, p < .001, d = 1.06, but not at F/U relative to POST, t(56) = .125, p = .901, d = 
0.02. 
Exploratory Analyses (Exposure Process Variables)  
 Exposure process data are presented in Table 3. 
Negative expectancy for harm. An independent samples t-test showed that the mean 
negative expectancy rating across exposure trials was greater for participants in the E/RP 
condition (M = 45.83, SD = 17.63) than in the E/JU condition (M = 34.91, SD = 18.73), t(55) = 
10.93, p = .027, d = 0.57. 
Attentional focus on challenging negative predictions. An independent samples t-test 
did not detect a significant mean difference in attentional focus rating across exposure trials 
between participants in the E/RP condition (M = 79.02, SD = 20.96) and E/JU condition (M = 
84.57, SD = 16.55), t(55) = 5.55, p = .271, d = 0.29. 
Attributions for exposure outcome. A one sample t-test showed that the mean number 
of safety behavior-related attributions made by participants in the E/JU condition (M = 0.31, SD 
= 0.66) was significantly different from zero and therefore unlikely to be due to chance, t(28) = 
0.31, p = .017, d = 0.47. 
Behavioral approach. Chi-square tests of independence could not be conducted as 
planned because the number of participants in each condition who did not meet their exposure 
goal fell below the minimum required value of 5 observations for a chi-square test (E/RP = 0; 
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E/JU = 2). Nor could a chi-square test be used to compare the rate of exposure goal completion 
between groups, as fewer than 5 participants met their exposure goal for the first time at Session 
4 (E/JU = 1). Visual inspection of the data (see Table 3) suggests that participants in the E/JU 
condition tended to reach their exposure goal earlier in treatment than did participants in the 
E/RP condition, although every E/RP participant met their exposure goal by the end of treatment.  
Discussion 
The “judicious use of safety behaviors” during exposure represents an ongoing 
controversy with important clinical implications. Previous studies have sought to elucidate the 
effects of safety behaviors on exposure, but no study on this topic has applied a longitudinal 
treatment design or delivered exposure from an inhibitory learning framework. Furthermore, 
although advocates and opponents of response prevention both propose reasonable pathways 
through which safety behaviors might impede or enhance exposure, few studies have directly 
assessed these potential mechanisms in addition to symptom outcomes. The current randomized 
controlled trial was therefore designed to extend previous work surrounding the safety behavior 
debate by (a) allowing for the incorporation and fading of safety behaviors over the course of 
treatment, (b) using multi-method assessment of short- and long-term exposure outcomes, (c) 
increasing the number and duration of treatment sessions to better resemble clinical practice, and 
(d) incorporating measures of inhibitory learning in a community sample of adults with spider 
phobia. 
Our primary hypothesis—that E/RP participants would demonstrate greater improvement 
than E/JU participants along self-report and behavioral symptom measures at follow-up but not 
posttreatment—was not supported. Participants in both conditions evidenced large (and 
statistically equivalent) reductions in self-reported and behavioral symptoms from pre- to 
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posttreatment, which were maintained over the follow-up period. Thus, our findings are 
inconsistent with research linking safety behavior use to poorer treatment outcome (Helbig-Lang 
& Petermann, 2010) and lend support to the claim that safety behaviors do not necessarily 
interfere with exposure (Rachman et al., 2008). However, it is important to bear in mind that 
whereas previous experiments on this topic (with the exception of Levy & Radomsky, 2016) 
required participants randomized to a safety behavior condition to use safety behaviors during 
the entirety of the exposure, our study is the first to systematically fade safety behavior use over 
the course of multiple exposure sessions. Consequently, our data should be interpreted to suggest 
that safety behaviors do not preclude symptom improvement as long as they are faded out in time 
for individuals to confront feared situations/stimuli without the use of any such behaviors.  
Regarding secondary outcomes, our hypothesis that treatment acceptability and 
tolerability would be greater for E/JU participants relative to E/RP participants before beginning 
exposures was not supported, as participants in both conditions reported statistically equivalent 
treatment perceptions across assessment time points. This is in contrast to studies showing 
greater consumer preference for exposure treatment permitting safety behaviors (Levy et al., 
2014; Milosevic & Radomsky, 2013a), but aligns with other work showing that traditional 
exposure and response prevention is perceived to be equally acceptable as exposure with safety 
behaviors (Deacon et al., 2012, 2013, 2010; Milosevic & Radomsky, 2013b). As noted elsewhere 
(Blakey & Abramowitz, 2016), this discrepancy in past work could be partially due to the limited 
descriptions of E/RP and E/JU provided in other studies, where often took the form of brief 
vignettes shown to nonclinical samples. The current study addresses this limitation of past work 
by administering a measure of treatment acceptability/tolerability to a clinical sample following a 
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full (60-minute) therapy session devoted to psychoeducation, discussing the treatment rationale, 
and collaborative treatment planning.  
It is also important to note that our observed treatment retention (95% completion) is 
inconsistent with the larger concern, held by some, that exposure faces a “refusal problem” or 
“unacceptably high” dropout rates. Although this could partially be due to the brevity of our 
intervention, our data do not lend support to the notion that safety behaviors increase patients’ 
willingness to agree to and complete exposure. That is, all participants who enrolled in this study 
consented to exposure, E/RP and E/JU participants perceived treatment to be equally acceptable, 
all but three participants completed treatment, and all but two participants (both E/JU) succeeded 
in meeting their exposure goal by the end of the third exposure. Of course, it also bears 
mentioning that because all participants voluntarily signed up for this study and gave informed 
consent, these individuals might not be representative of adults with spider phobia in general. 
This study’s therapist training sequence also emphasized the importance of (a) providing a 
convincing and coherent treatment rationale and (b) communicating confidence in participants 
and the treatment approach as critical components of the intervention. Furthermore, therapists 
received regular (i.e., at least weekly) supervision, which is not typical of general clinical 
practice. Although beyond the scope of the available data, it could be that such therapist-specific 
factors are more critical predictors of treatment refusal/dropout than are treatment- or participant-
related factors (at least in the context of brief interventions for specific phobia). Future research 
directly assessing the relationship between therapist characteristics, exposure delivery, and 
treatment acceptability/tolerability would be helpful. 
Our other secondary hypotheses—that E/RP participants, relative to E/JU participants, 
would report lower peak distress and greater distress tolerance during an in vivo spider-related 
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behavioral task at follow-up—was likewise not supported by the data. Specifically, participants 
in both conditions evidenced significant improvement on both indices from pre- to posttreatment, 
which did not deteriorate over the follow-up period. Some investigators have suggested that 
increasing a patient’s ability to tolerate psychological distress tolerance is critical to inhibitory 
learning (Abramowitz & Arch, 2014; Blakey & Abramowitz, 2016). To our knowledge, this is 
the first safety behavior study to measure perceived distress tolerance in addition to distress 
intensity. Future research on safety behaviors (and inhibitory learning models of exposure in 
general) should continue to examine the importance of distress tolerance to treatment outcome. 
In light of certain limitations to assessing distress tolerance via self-report (Magidson, Ali, 
Listhaus, & Daughters, 2013), investigators might further consider alternative approaches to 
measuring this construct in the context of exposure therapy. 
Findings from exploratory analyses of exposure process variables were partially in line 
with theoretical accounts. According to the inhibitory learning model of exposure therapy 
(Craske et al., 2008, 2014), exposure is most effective when negative expectancies (e.g., being 
bitten by a spider) are maximally violated. This assumption is based on basic learning research 
suggesting that being “pleasantly surprised” (e.g., not being bitten by a spider) is therapeutically 
useful; the greater the surprise, the stronger the inhibitory learning (Rescorla & Wagner, 1972). 
Some have argued that using safety behaviors—which, by definition, are perceived to minimize 
the risk of a feared outcome—inherently attenuates the discrepancy between (and thus the 
potential violation of) a fear-based expectation and an actual exposure outcome (Blakey & 
Abramowitz, 2016). That pre-exposure negative expectancies were significantly higher among 
participants conducting exposure without safety behaviors in this study is consistent with 
inhibitory learning-based arguments against incorporating safety behaviors into exposure. 
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Contrary to information processing accounts (Sloan & Telch, 2002), we did not detect a 
difference in self-reported attentional focus toward belief testing during exposure as a function of 
safety behavior use. Although our study does not provide support for the claim that safety 
behaviors interfere with a patient’s ability to process disconfirmatory information when 
confronting feared situations/stimuli, attentional focus ratings may have been biased in this study 
due to participant demand characteristics or inaccurate estimations of an automatic cognitive 
process. Future research on this proposed explanation for safety behaviors’ deleterious effects 
should incorporate objective (and perhaps implicit) measures of directed attention.  
Our results are in line with the often-cited proposition that patients are prone to 
misattribute the non-occurrence of a feared exposure outcome to safety behaviors (e.g., “that 
spider did not bite me because I was wearing gloves”; Salkovskis, 1991). Specifically, 
participants in the E/JU condition made more safety-behavior related attributions than would be 
expected by chance, which suggests that individuals performing safety behaviors during 
exposure therapy do not entirely conclude that their fear-based predictions are exaggerated 
and/or irrational. Thus, one clinical implication of the current study is that therapists should 
explicitly frame a successful exposure outcome as discordant with the preconceived expectancy, 
making sure that their patients “give credit where credit is due” (i.e., not to a safety behavior) 
following a successful exposure task. 
 Results were somewhat consistent with previous research suggesting that anxious 
individuals can more quickly approach feared situations/stimuli when using safety behaviors 
(e.g., Hood et al., 2010). The degree to which differential rates of approach affect ultimate 
exposure success, however, appears negligible. Whereas as all E/RP participants met their 
exposure goal by the end of the third exposure, two E/JU participants did not meet their exposure 
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goal at any point during treatment and two additional E/JU participants were only able to reach 
their goal when using safety behaviors (i.e., they met their goal within the first two exposure 
sessions but did not meet their goal during the final exposure session, when safety behaviors 
were completely faded). Some experts (Jacoby, Abramowitz, Blakey, & Reuman, 2018) have 
argued that anticipatory anxiety regarding building up to more challenging exposure tasks (e.g., 
attempting to complete a previously achieved task but this time without safety behaviors) itself 
can cause patient dropout or decreases in self-efficacy. Therefore, a therapist should carefully 
consider whether it is in their patient’s best interest to approximate exposure goal completion via 
the strategic use of anxiety-reducing behaviors as opposed to budgeting an additional session (or 
sessions) for patients to attempt their exposure goal without the use of such behaviors. 
On a broader level, our results are in line with the substantial body of research on the 
efficacy of exposure therapy for clinical anxiety; primary outcome effect sizes ranged from 2.13 
to 2.28 (well above the recognized Cohen’s d cutoff value of 0.80 designating a “large” effect) 
and the sample did not exhibit relapse on any outcome measure at follow-up. These findings 
underscore the therapeutic potency of direct confrontation with feared (yet safe) 
situations/stimuli. That participants in our study demonstrated such notable symptom reduction 
in just four sessions aligns with other research on the efficacy of brief (i.e., one- to five-session) 
interventions for specific phobia (Choy et al., 2007). In fact, it could be that by building on 
previous safety behavior research and delivering a full course of exposure therapy, we ironically 
“washed out” our ability to find a true safety behavior effect. Thus, it would be important for 
future investigators to continue examining differential patterns of treatment response in addition 
to global changes in symptom severity after a full “dose” of exposure therapy (Clapp, Kemp, 
Cox, & Tuerk, 2016; Tuerk, 2014).  
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This study had several strengths, including the use of distinctive treatment and 
assessment stimuli, recruitment of a clinical sample, and solicitation of input on study design 
from both E/RP and E/JU experts. More importantly, this study built upon the body of existing 
work by incorporating important methodological features such as longitudinal design, 
multimethod assessment, and measurement of psychological mechanisms relevant to inhibitory 
learning. Using a longitudinal design not only enhanced ecological validity (i.e., multiple 
sessions of exposure more closely resembles naturalistic treatment programs than do single-
session paradigms), but also allowed for the first test of fading “judiciously used” safety 
behaviors as initially defined (Rachman et al., 2008). 
At the same time, findings from this study should be understood within the context of 
several limitations. First, although this study used a clinical sample of adults recruited from the 
community, the sample was fairly homogeneous with respect to many demographic variables. 
Relatedly, we tested our hypotheses in the context of spider phobia; as such, findings may not 
generalize to other specific phobias or to more complex anxiety-related conditions. It is also 
worth noting that we compared the novel E/JU approach to a positive control group (i.e., 
traditional E/RP), but did not include an inactive (i.e., placebo) control group. Therefore, we 
cannot rule out passage of time and/or non-specific factors (e.g., expectation effects) in the 
interpretation of our results. Considering the extensive accumulated research demonstrating the 
efficacy and effectiveness of E/RP (e.g., Choy et al., 2007; Olatunji et al., 2010), however, our 
lack of an inactive control group is not a major concern.  
Another set of limitations regards the way we operationalized the judicious use of safety 
behaviors in this study. Because this was the first longitudinal test of the “judicious use” 
approach to exposure therapy, we elected to preserve internal validity where possible, sometimes 
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at the expense of external validity. For example, although we allowed for participants to self-
select from several safety behaviors to match their personal preferences and/or exposure goal, it 
is possible that participants would use alternative safety behaviors in naturalistic settings. We 
also used a standardized safety behavior fading schedule over the course of treatment for 
participants in the E/JU condition. Although this allowed us to control the “dose” of safety 
behaviors across exposure sessions, true clinical practice would likely involve more therapist–
patient negotiation regarding when and how to fade safety behaviors. In fact, preliminary 
evidence suggests that allowing patients to determine when to fade safety behavior use is more 
beneficial than therapist-driven safety behavior fading (Levy & Radomsky, 2016). 
Although we assessed mechanisms thought to primarily explain safety behaviors’ 
drawbacks and advantages (Blakey & Abramowitz, 2016), we did not measure other potentially 
important factors (e.g., session-by-session changes in self-efficacy; Levy & Radomsky, 2016). 
Alternatively, it could be that there are important moderators not considered in our analysis. For 
example, individuals with greater levels of initial spider-related self-efficacy may not benefit 
from incorporating safety behaviors into exposures, whereas strategic use of safety behaviors 
could enhance treatment outcome for individuals with low levels of pretreatment self-efficacy. 
Another empirical question that could be addressed in future work is whether safety behavior 
effects are conditioned by the safety behavior’s primary function. Specifically, it is possible that 
safety behaviors perceived to prevent a patient’s feared outcome (e.g., creating a barrier to avoid 
being bitten) are more prone to cause safety misattributions and attenuate the potential violation 
of negative expectancies, whereas safety behaviors that merely serve to reduce associated 
distress (e.g., reassurance seeking) are less likely to interfere with fear extinction. Future 
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research might strive to examine the specific conditions under which safety behaviors are 
helpful, versus harmful, in the context of exposure. 
One final consideration is that we tested the judicious use of safety behaviors—a 
proposal developed from a cognitive perspective—within an inhibitory learning framework. 
Although inhibitory learning theory overlaps with cognitive theory in many respects (e.g., a 
“negative expectancy” within the inhibitory learning model is akin to an “irrational belief” 
important to cognitive models), these two approaches emphasize different treatment objectives. 
Whereas cognitive therapy focuses on changing beliefs, inhibitory learning-based exposure 
therapy focuses on generating and strengthening new beliefs. Thus, although one would not 
expect empirical findings to vary as a function of the investigators’ theoretical orientation, it is 
possible that our approach to treatment delivery and assessment prevented us from capturing 
certain features of E/JU that might have been given greater attention within a cognitive 
framework. At the same time, it could be that applying the inhibitory learning model sheds light 
on previously unconsidered benefits of permitting safety behaviors during exposure. For 
example, theory suggests that fluctuations in the learning context (e.g., variable exposure 
intensity, stimuli, and settings) helps to strengthen inhibitory associations (Craske et al., 2014; 
Jacoby & Abramowitz, 2016). It is therefore possible that safety behaviors promote inhibitory 
learning to the extent that they function to introduce variability into exposure, versus 
contextualize inhibitory associations.  
In summary, we did not find the predicted deleterious effects of safety behavior use on 
long-term treatment outcome following a course of exposure therapy for specific phobia, but nor 
did our study yield support for most purported advantages of judiciously incorporating safety 
behaviors into treatment. Additionally, our findings offer preliminary evidence for an effect of 
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safety behavior use on inhibitory learning and behavioral approach across exposure sessions. 
Results from this study collectively suggest that although exposure therapy is difficult to 
improve upon, it also difficult to undermine (e.g., by sometimes using safety behaviors) if 
otherwise delivered in a prolonged and intense manner. Extrapolating to clinical practice, 
therapists may not need to be concerned if their patient is unwilling to comply with response 
prevention at the start of exposure as long as patients (b) explicitly test their fear-based negative 
expectancies through direct and sustained confrontation with feared situations/stimuli and (b) 










Safety behavior selection and helpfulness ratings among E/JU completers (n = 29) 
Safety item Helpfulness rating 
Selected as  
most helpful 
Selected as  
second-most helpful 
 M SD Range n % n % 
Long chemistry gloves 8.34 2.73 0-10 22 75.86 1 3.45 
Short work gloves 6.41 2.58 0-10 5 17.24 1 3.45 
Long-sleeve rain jacket 4.76 3.17 0-10 1 3.45 4 13.79 
Plastic shield 3.97 3.35 0-10 1 3.45 11 37.93 
Apron 2.72 2.55 0-9 0 0.00 4 13.79 
Visor face shield 2.55 3.20 0-9 0 0.00 4 13.79 
Boot/shoe covers 2.55 2.93 0-9 0 0.00 3 10.34 











Outcome descriptive data for treatment completers across assessment time points 
 
Outcome 
Total sample (N = 57) E/RP (n = 28) E/JU (n = 29) 
M SD Range M SD Range M SD Range 
FSQ          
PRE 90.19 19.80 46-125 95.64 19.72 46-125 84.93 18.72 52-112 
POST 28.56 21.10 0-77 30.79 19.27 0-64 26.41 22.86 1-77 
F/U 30.32 21.87 0-78 30.79 21.38 0-78 29.86 22.70 0-74 
BAT steps          
PRE 6.11 2.79 0-9 5.96 2.83 0-9 6.24 2.80 1-9 
POST 11.44 2.21 3-13 11.43 2.52 3-13 11.45 1.92 7-13 
F/U 11.61 2.14 4-13 11.68 2.28 4-13 11.55 2.03 7-13 
TAAS          
Session 1 53.63 6.38 42-69 53.68 5.65 43-63 53.59 7.11 42-69 
POST 62.11 6.17 43-70 62.75 4.73 51-70 61.48 7.33 43-70 
F/U 61.33 6.88 44-70 61.93 6.56 44-70 60.76 7.24 46-70 
Peak BAT distress          
PRE 12.98 5.07 0-20 12.81 5.37 4-20 13.14 4.87 0-20 
POST 7.51 6.03 0-20 8.50 6.24 0-20 6.55 5.76 0-20 
F/U 7.21 5.39 0-20 7.71 5.50 0-20 6.72 5.33 0-20 
BAT distress tolerance          
PRE 6.30 2.63 0-10 5.88 2.44 1-9 6.66 2.78 0-10 
POST 9.05 1.36 4-10 8.89 1.34 5-10 9.21 1.37 4-10 
F/U 9.07 1.27 5-10 9.07 1.21 7-10 9.07 1.33 5-10 
Note. FSQ = Fear of Spiders Questionnaire; BAT = Behavioral approach test; TAAS = Treatment Acceptability/Adherence Scale; 
PRE = Pretreatment assessment; POST = Posttreatment assessment; F/U = 1-month follow-up assessment; E/RP = Exposure and 









Exposure process data for treatment completers across exposure trials 
 
Continuous Variables 
Total sample (N = 57) E/RP (n = 28) E/JU (n = 29) 
M SD Range M SD Range M SD Range 
Negative expectancy (%)          
Exposure 1 62.98 27.83 0-100 71.90 21.73 10-100 54.37 30.61 0-100 
Exposure 2 35.36 24.95 0-90 43.28 25.57 10-90 27.45 21.98 0-90 
Exposure 3 21.75 20.90 0-85 21.79 22.58 0-85 21.72 19.53 0-70 
Attentional focus (%)          
Exposure 1 77.29 22.34 5-100 74.17 25.14 5-100 80.30 19.22 40-100 
Exposure 2 81.84 23.94 0-100 78.10 26.10 0-100 85.59 21.36 20-100 
Exposure 3 85.86 20.26 10-100 84.89 20.79 20-100 86.79 20.06 10-100 
 
Ordinal Variables 
Total sample (N = 57) E/RP (n = 28) E/JU (n = 29) 
n % n % n % 
Met exposure goal        
No 2 3.51 0 0.00 2 6.90 
Yes 53 92.98 28 100.00 25 83.33 
Yes (with safety 
behaviors only) 
2 3.51 - - 2 6.90 
Exposure goal first met       
Never met goal 2 3.51 0 0.00 2 6.90 
Exposure 1 17 29.82 7 25.00 10 34.48 
Exposure 2 27 47.37 11 39.29 16 55.17 










































Figure 1. CONSORT Flow Diagram. 
  
Assessed for eligibility (n = 114) 
Excluded (n = 54) 
   Did not pass initial phone screen (n = 16) 
   Completed ≥10 BAT steps at PRE (n = 3) 
   Declined to participate (n = 35) 
Treatment completers (n = 28) 
Lost to follow-up (n = 0) 
Treatment completers (n = 29) 
 
Analysis 
Randomized (n = 60) 
Enrollment 
Allocated to E/RP (n = 30) 
 Received allocated intervention (n = 28) 
 Dropped out from intervention (n = 2) 
 Scheduling conflict (n = 1) 
 Unknown reason (n = 1) 
 
 
Allocated to E/JU (n = 30) 
 Received allocated intervention (n = 29) 
 Dropped out from intervention (n = 1) 
 Unknown reason (n = 1) 
 
Allocation 











treatment dose within 
and between 
conditions 
• Study personnel matched the number and duration of sessions 
• Providers used kitchen timer to standardize exposure duration 
for all participants and sessions  
• Treatment manual text was identical for both conditions except 
for safety behavior manipulation 
Training providers 
Standardize training • Same clinical instructor trained all treatment providers 
• Providers were trained together (when possible) 
• Trainer used standardized training materials and curriculum 
• Trainer used structured practice and role-playing 
Ensure provider skill 
acquisition 
• Trainer observed intervention implementation with pilot 
participants via audio/video recordings 
• Answers to common clinical issues/questions were saved in a 
shared folder and reviewed as a group  




• Trainer used provider-centered training according to provider’s 
needs, background, and clinical experience 
• Trainer encouraged providers to attend clinical workshops or 
training programs offered by the study site (e.g., LGBT 
sensitivity and awareness training) 
Minimize “drift” in 
provider skills 
• Trainer conducted regular observation of recorded encounters 
and provided individual and group supervision at least weekly 
• Trainer allowed providers easy access for supervision and 
questions about the intervention outside of regular supervision 
• Trainer regularly monitored therapist adherence to manual 
• Providers self-reported adherence to the manual via a 




Delivery of treatment 
Control for provider 
differences 
• Providers worked with all treatment groups 
• Analyst coded and compared providers’ non-specific skills 
Reduce differences 
within treatment 
• Providers used scripted intervention protocol  
• Trainer regularly monitored therapist adherence to manual 
Ensure adherence to 
treatment protocol 
• Trainer conducted regular observation of recorded encounters 
and monitored therapist adherence to manual 
• Trainer ensured provider comfort in self-reporting deviations 
from the treatment manual to the supervisor  
• Trainer regularly reviewed recordings for errors of content 
omission and commission 
• 15% of sessions randomly selected for fidelity evaluation 
• Fidelity coders reviewed tapes without knowing treatment 




• Providers used scripted intervention protocol 
• Providers delivered condition-specific rationales verbatim  
• Trainer gave providers a convincing rationale for minimizing 
contamination between conditions 
• Trainer conducted regular observation of recorded encounters 
and monitored therapist adherence to manual 
Receipt of treatment 
Ensure participant 
comprehension 
• Providers solicited feedback and personal examples of 
psychoeducational material to demonstrate understanding 
• Intervention protocol prompted providers to frequently ask if 
the participant had any questions or wanted any clarification 
Enactment of treatment skills 
Ensure participant use 
of cognitive skills 
• Providers used Socratic and open-ended questioning  
• Participants led psychoeducation review at Sessions 2-4 
• Providers assessed use of skills during post-exposure processing  
Ensure participant use 
of behavioral skills 
• Providers narrated and encouraged approach behavior 
throughout exposure sessions  
• Providers assessed behavioral progress variables throughout the 
intervention period 
1 Bellg, A. J., Borrelli, B., Resnick, B., Hecht, J., Minicucci, D. S., Ory, M., & ... Czajkowski, S. 
(2004). Enhancing Treatment Fidelity in Health Behavior Change Studies: Best Practices and 
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